Original Research17 May 2023Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1–2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapySeung Eun Lee, 6 more and Soong June Bae1,658 views2 citations
Loading...Systematic Review12 May 2023Best treatment options for occult breast cancer: A meta-analysisRong Wang, 3 more and Qing Lv4,129 views0 citations
Original Research13 March 2023Indo-cyanine green administration to identify loss of lymph after axillary lymph node dissectionMirela Mariana Roman, 3 more and Pierre Bourgeois1,033 views0 citations
Loading...Original Research02 February 2023Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltrationZhengwei Gui, 4 more and Lin Zhang1,068 views3 citations
Loading...Review23 December 2022Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A reviewRan Ran, 3 more and Jiao Yang3,675 views4 citations
Original Research12 December 2022Use of period analysis to timely assess 5-year relative survival for breast cancer patients from Taizhou, Eastern ChinaRunhua Li, 14 more and Tianhui Chen1,509 views1 citations
Case Report30 November 2022Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature reviewZhaohui Chu1,832 views2 citations